primescript reverse transcriptase (Biostar Inc)
90
Structured Review
Biostar Inc
primescript reverse transcriptase
Primescript Reverse Transcriptase, supplied by Biostar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript%E2%84%A2+reverse+transcriptase/primescript+reverse+transcriptase/pm28439677-54-5-8
Average 90 stars, based on 1 article reviews
Primescript Reverse Transcriptase, supplied by Biostar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript%E2%84%A2+reverse+transcriptase/primescript+reverse+transcriptase/pm28439677-54-5-8
Average 90 stars, based on 1 article reviews
primescript reverse transcriptase - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Synthesized:Article Title: AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Article Snippet: Cancers are the second leading causes of death worldwide, with gastric cancer (GC) remaining one of the most common malignancies [1].. Although the treatment methods for gastric carcinoma have made great progress over the past 2 decades, a large number of patients still fail to achieve complete remission or suffer relapse due to the phenomenon of multidrug resistance (MDR).. The complicated mechanisms of MDR in cancer cells include increased drug efflux, redistribution of intracellular drug accumulation, alterations in the drug’s target molecules, increased DNA damage repair, and suppression of drug-induced cell apoptosis [2–4]. Reverse Transcription:Article Title: AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Article Snippet: Cancers are the second leading causes of death worldwide, with gastric cancer (GC) remaining one of the most common malignancies [1].. Although the treatment methods for gastric carcinoma have made great progress over the past 2 decades, a large number of patients still fail to achieve complete remission or suffer relapse due to the phenomenon of multidrug resistance (MDR).. The complicated mechanisms of MDR in cancer cells include increased drug efflux, redistribution of intracellular drug accumulation, alterations in the drug’s target molecules, increased DNA damage repair, and suppression of drug-induced cell apoptosis [2–4]. |